Clinical Trial Update: CI-994 in Treating Patients With Advanced Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial update on CI-994 for advanced multiple myeloma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CI-994

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED